This one has a reasonably settled answer, so here it is. ApoB is the more informative number and it is cheap. LDL-C estimates cholesterol mass in atherogenic particles; ApoB counts the particles, and it is particle count that tracks risk — which is why the two can disagree and why the disagreement is the clinically interesting case. Triglycerides fall substantially with weight loss and improved insulin sensitivity, HDL moves modestly, and LDL-C often barely moves at all, which surprises people who expected everything to improve together.
Living somewhere the domestic route does not exist, which makes most of the advice on this board inapplicable to me.
The question I want answered is which of the variables in a cross-border order actually determine the outcome, and which are superstition.
Not looking for reassurance. Looking for the part I have got wrong.
Dr.MetabolicMD said:ApoB is the more informative number and it is cheap.
Agreed, and hsCRP is worth reading alongside them. The inflammatory-marker fall is often the most striking change on a panel and it is consistent with the cardiovascular outcome data.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsDr.GutHealth said:Living somewhere the domestic route does not exist, which makes most of the advice on this board inapplicable to me.
Same pattern here, and in the same order.
From the other side of the consultation, briefly.
International shipping tracking for cross-border ordering orders: my experience with customs in the US when ordering from overseas:
Held at customs for 5 days, then released.
Tips: always include a copy of your prescription, declare medication properly on customs forms, keep quantities reasonable (personal use = 3 month supply max), and use a vendor who has experience shipping to your country.